
TY  - JOUR
TI  - Pharmacology and Anaesthesia
JO  - European Journal of Anaesthesiology
VL  - 18
IS  - s22
SN  - 0265-0215
UR  - https://doi.org/10.1046/j.1365-2346.2001.00001.x
DO  - doi:10.1046/j.1365-2346.2001.00001.x
SP  - 1
EP  - 42
PY  - 2001
ER  - 

TY  - JOUR
TI  - 2011 American College of Veterinary Surgeons Veterinary Symposium November 3–5, Chicago, Illinois
JO  - Veterinary Surgery
JA  - Veterinary Surgery
VL  - 40
IS  - 7
SN  - 0161-3499
UR  - https://doi.org/10.1111/j.1532-950X.2011.00896.x
DO  - doi:10.1111/j.1532-950X.2011.00896.x
SP  - E17
EP  - E42
PY  - 2011
ER  - 

TY  - JOUR
TI  - Posters
JO  - Mycoses
JA  - Mycoses
VL  - 58
IS  - S3
SN  - 0933-7407
UR  - https://doi.org/10.1111/myc.12362
DO  - doi:10.1111/myc.12362
SP  - 40
EP  - 68
PY  - 2015
ER  - 

TY  - JOUR
TI  - ASBMR 30th Annual Meeting SU001–SU504
JO  - Journal of Bone and Mineral Research
JA  - J Bone Miner Res
VL  - 23
IS  - S1
SN  - 0884-0431
UR  - https://doi.org/10.1002/jbmr.5650231305
DO  - doi:10.1002/jbmr.5650231305
SP  - S243
EP  - S373
PY  - 2008
ER  - 

AU  - Latifi, Rifat
AU  - Con, Jorge
C7  - pp. 177-188
TI  - Nutrition Support in Critically Ill Patients
SN  - 9781119317920
UR  - https://doi.org/10.1002/9781119317913.ch19
DO  - doi:10.1002/9781119317913.ch19
SP  - 177-188
KW  - albumin
KW  - biologic factor
KW  - clinical factor
KW  - critically ill patients
KW  - nutrition support
KW  - surgical interventions
KW  - total parenteral nutrition
KW  - transferrin
PY  - 2008
AB  - Summary This is a unique question-and-answer chapter for surgical residents and trainees, concentrating on the nutrition support in critically ill patients. The negative acute phase proteins are albumin and transferrin. Their serum concentrations fall immediately after the injury, in proportion to its severity. They are used to monitor the nutritional status of acutely ill patients. Areas of intense clinical investigation in which total parenteral nutrition (TPN) may eventually be shown to be of great value are cancer patients in general, sepsis and trauma, and general perioperative support to prevent or correct malnutrition. Although protein restriction was historically used to reduce risk from hepatic encephalopathy, such a strategy may worsen nutrition status, decrease lean muscle mass, and ironically lead to less ammonia removal. Many interacting biologic and clinical factors are responsible for the development of malnutrition in critically ill and injured hospitalized patients and also the hypercatabolic states associated with trauma, sepsis, cancer, and surgical interventions.
ER  - 

TY  - JOUR
TI  - Annual Scientific Meeting of the British Association of Oral Surgeons, London 2011
JO  - Oral Surgery
VL  - 5
IS  - 2
SN  - 9781119317920
UR  - https://doi.org/10.1111/j.1752-248X.2012.01154.x
DO  - doi:10.1111/j.1752-248X.2012.01154.x
SP  - 84
EP  - 107
PY  - 2012
ER  - 

TY  - JOUR
AU  - Lee, Hae In
AU  - Lee, Sae-Won
AU  - Kim, Nam Gyun
AU  - Park, Kyoung-Jun
AU  - Choi, Byung Tae
AU  - Shin, Yong-Il
AU  - Shin, Hwa Kyoung
TI  - Low-level light emitting diode (LED) therapy suppresses inflammasome-mediated brain damage in experimental ischemic stroke
JO  - Journal of Biophotonics
JA  - J. Biophoton.
VL  - 10
IS  - 11
SN  - 9781119317920
UR  - https://doi.org/10.1002/jbio.201600244
DO  - doi:10.1002/jbio.201600244
SP  - 1502
EP  - 1513
KW  - Focal cerebral ischemia
KW  - NLRP3
KW  - TLR2
KW  - neuroprotection
KW  - photostimulation 
PY  - 2017
AB  - Use of photostimulation including low-level light emitting diode (LED) therapy has broadened greatly in recent years because it is compact, portable, and easy to use. Here, the effects of photostimulation by LED (610 nm) therapy on ischemic brain damage was investigated in mice in which treatment started after a stroke in a clinically relevant setting. The mice underwent LED therapy (20 min) twice a day for 3 days, commencing at 4 hours post-ischemia. LED therapy group generated a significantly smaller infarct size and improvements in neurological function based on neurologic test score. LED therapy profoundly reduced neuroinflammatory responses including neutrophil infiltration and microglia activation in the ischemic cortex. LED therapy also decreased cell death and attenuated the NLRP3 inflammasome, in accordance with down-regulation of pro-inflammatory cytokines IL-1? and IL-18 in the ischemic brain. Moreover, the mice with post-ischemic LED therapy showed suppressed TLR-2 levels, MAPK signaling and NF-kB activation. These findings suggest that by suppressing the inflammasome, LED therapy can attenuate neuroinflammatory responses and tissue damage following ischemic stroke. Therapeutic interventions targeting the inflammasome via photostimulation with LED may be a novel approach to ameliorate brain injury following ischemic stroke. Effect of post-ischemic low-level light emitting diode therapy (LED-T) on infarct reduction was mediated by inflammasome suppression.
ER  - 

TY  - JOUR
TI  - Thematic Poster Sessions – Tuesday
JO  - Allergy
VL  - 66
IS  - s94
SN  - 9781119317920
UR  - https://doi.org/10.1111/j.1398-9995.2011.02608.x
DO  - doi:10.1111/j.1398-9995.2011.02608.x
SP  - 482
EP  - 642
PY  - 2011
ER  - 

TY  - JOUR
TI  - Poster Session Abstracts
JO  - Pediatric Pulmonology
JA  - Pediatr Pulmonol.
VL  - 52
IS  - S47
SN  - 9781119317920
UR  - https://doi.org/10.1002/ppul.23840
DO  - doi:10.1002/ppul.23840
SP  - S214
EP  - S516
PY  - 2017
ER  - 

TY  - JOUR
TI  - POSTER SESSIONS
JO  - Allergy
VL  - 62
IS  - s83
SN  - 9781119317920
UR  - https://doi.org/10.1111/j.1398-9995.2007.01407.x
DO  - doi:10.1111/j.1398-9995.2007.01407.x
SP  - 167
EP  - 551
PY  - 2007
ER  - 

TY  - JOUR
AU  - CHASE, VICKI
AU  - NEILD, ROSE
AU  - SADLER, CRAIG W.
AU  - BATEY, ROBERT G.
TI  - The medical complications of alcohol use: understanding mechanisms to improve management
JO  - Drug and Alcohol Review
VL  - 24
IS  - 3
SN  - 9781119317920
UR  - https://doi.org/10.1080/09595230500167510
DO  - doi:10.1080/09595230500167510
SP  - 253
EP  - 265
KW  - alcohol
KW  - alcohol-related tissue injury
KW  - cytokines
KW  - drug metabolism
KW  - genetic susceptibility
KW  - organ damage
KW  - oxidative stress
PY  - 2005
AB  - Abstract The use of alcohol in a dependent or even a regular heavy pattern predisposes the drinker to a range of adverse consequences. These include a risk of direct harm from alcohol, including organ damage, mental health disorders and a range of social and legal problems associated with behaviours due to alcohol's effects. The range of organ damage associated with regular heavy alcohol consumption is well described. Much new information on the mechanisms by which damage occurs is available and is reviewed in this paper. New knowledge can assist in the development of more appropriate management strategies for those affected by the medical complications of alcohol use. Genetic susceptibility to tissue injury is explored and the reasons why many heavy drinkers do not appear to experience organ damage are considered. Approaches to the management of certain alcohol-related disorders are outlined.
ER  - 

TY  - JOUR
AU  - Pierre, Joseph F.
AU  - Heneghan, Aaron F.
AU  - Lawson, Christy M.
AU  - Wischmeyer, Paul E.
AU  - Kozar, Rosemary A.
AU  - Kudsk, Kenneth A.
TI  - Pharmaconutrition Review
JO  - Journal of Parenteral and Enteral Nutrition
JA  - Journal of Parenteral and Enteral Nutrition
VL  - 37
IS  - 5S
SN  - 9781119317920
UR  - https://doi.org/10.1177/0148607113493326
DO  - doi:10.1177/0148607113493326
SP  - 51S
EP  - 65S
KW  - immunonutrition
KW  - pharmaconutrition
KW  - immune modulation
KW  - nutrition therapy
PY  - 2013
AB  - The search to improve outcomes in critically ill patients through nutrition support has steadily progressed over the past 4 decades. One current approach to this problem is the addition of specific nutrients as primary therapy to improve host defenses and improve the outcome of critically ill patients. The field is referred to as ?pharmaconutrition,? with the hope of focusing investigations on each nutrient to understand its pharmacological effects on immune and clinical outcomes. The purpose of this review is to describe some of the known physiological mechanisms of pharmaconutrients such as glutamine, arginine, ?-3 fatty acids, and selenium.
ER  - 

TY  - JOUR
TI  - Abstracts Published Only
JO  - Journal of Digestive Diseases
JA  - Journal of Digestive Diseases
VL  - 19
IS  - S1
SN  - 9781119317920
UR  - https://doi.org/10.1111/1751-2980.12665
DO  - doi:10.1111/1751-2980.12665
SP  - 49
EP  - 146
PY  - 2018
ER  - 

TY  - JOUR
AU  - Dubin, Patricia J.
AU  - Kolls, Jay K.
TI  - Th17 cytokines and mucosal immunity
JO  - Immunological Reviews
VL  - 226
IS  - 1
SN  - 9781119317920
UR  - https://doi.org/10.1111/j.1600-065X.2008.00703.x
DO  - doi:10.1111/j.1600-065X.2008.00703.x
SP  - 160
EP  - 171
KW  - Th17
KW  - IL-17A
KW  - IL-17F
KW  - IL-22
KW  - vaccine
KW  - mucosa
PY  - 2008
AB  - Summary: The T-helper 17 (Th17) lineage is a recently described subset of memory T cells that is characterized by its CD4+ status and its ability to make a constellation of cytokines including interleukin-17A (IL-17A), IL-17F, IL-22, and, in humans, IL-26. Although most extensively described in the autoimmunity literature, there is growing evidence that the Th17 lineage plays a significant role in mediating host mucosal immunity to a number of pulmonary pathogens. This review highlights our current understanding of the role of the Th17 lineage and Th17 cytokines in mediating mucosal immunity to both pulmonary and gastrointestinal pathogens. While we have the strongest evidence that the Th17 lineage is centrally involved in mediating the host response to Gram-negative extracellular pulmonary pathogens, this literature is rapidly evolving and demonstrates a central role for Th17 cytokines both in primary infection and in recall responses seen in vaccine studies. In this review, we summarize the current state of this literature and present possible applications of Th17-targeted immunotherapy in the treatment and prevention of infection.
ER  - 

TY  - JOUR
AU  - Orlandi, Richard R.
AU  - Kingdom, Todd T.
AU  - Hwang, Peter H.
AU  - Smith, Timothy L.
AU  - Alt, Jeremiah A.
AU  - Baroody, Fuad M.
AU  - Batra, Pete S.
AU  - Bernal-Sprekelsen, Manuel
AU  - Bhattacharyya, Neil
AU  - Chandra, Rakesh K.
AU  - Chiu, Alexander
AU  - Citardi, Martin J.
AU  - Cohen, Noam A.
AU  - DelGaudio, John
AU  - Desrosiers, Martin
AU  - Dhong, Hun-Jong
AU  - Douglas, Richard
AU  - Ferguson, Berrylin
AU  - Fokkens, Wytske J.
AU  - Georgalas, Christos
AU  - Goldberg, Andrew
AU  - Gosepath, Jan
AU  - Hamilos, Daniel L.
AU  - Han, Joseph K.
AU  - Harvey, Richard
AU  - Hellings, Peter
AU  - Hopkins, Claire
AU  - Jankowski, Roger
AU  - Javer, Amin R.
AU  - Kern, Robert
AU  - Kountakis, Stilianos
AU  - Kowalski, Marek L.
AU  - Lane, Andrew
AU  - Lanza, Donald C.
AU  - Lebowitz, Richard
AU  - Lee, Heung-Man
AU  - Lin, Sandra Y.
AU  - Lund, Valerie
AU  - Luong, Amber
AU  - Mann, Wolf
AU  - Marple, Bradley F.
AU  - McMains, Kevin C.
AU  - Metson, Ralph
AU  - Naclerio, Robert
AU  - Nayak, Jayakar V.
AU  - Otori, Nobuyoshi
AU  - Palmer, James N.
AU  - Parikh, Sanjay R.
AU  - Passali, Desiderio
AU  - Peters, Anju
AU  - Piccirillo, Jay
AU  - Poetker, David M.
AU  - Psaltis, Alkis J.
AU  - Ramadan, Hassan H.
AU  - Ramakrishnan, Vijay R.
AU  - Riechelmann, Herbert
AU  - Roh, Hwan-Jung
AU  - Rudmik, Luke
AU  - Sacks, Raymond
AU  - Schlosser, Rodney J.
AU  - Senior, Brent A.
AU  - Sindwani, Raj
AU  - Stankiewicz, James A.
AU  - Stewart, Michael
AU  - Tan, Bruce K.
AU  - Toskala, Elina
AU  - Voegels, Richard
AU  - Wang, De Yun
AU  - Weitzel, Erik K.
AU  - Wise, Sarah
AU  - Woodworth, Bradford A.
AU  - Wormald, Peter-John
AU  - Wright, Erin D.
AU  - Zhou, Bing
AU  - Kennedy, David W.
TI  - International Consensus Statement on Allergy and Rhinology: Rhinosinusitis
JO  - International Forum of Allergy & Rhinology
JA  - Int Forum Allergy Rhinol.
VL  - 6
IS  - S1
SN  - 9781119317920
UR  - https://doi.org/10.1002/alr.21695
DO  - doi:10.1002/alr.21695
SP  - S22
EP  - S209
KW  - rhinosinusitis
KW  - chronic rhinosinusitis
KW  - acute rhinosinusitis
KW  - recurrent acute rhinosinusitis
KW  - evidence-based medicine
KW  - systematic review
KW  - endoscopic sinus surgery
PY  - 2016
AB  - Contributing Authors Isam Alobid, MD, PhD1, Nithin D. Adappa, MD2, Henry P. Barham, MD3, Thiago Bezerra, MD4, Nadieska Caballero, MD5, Eugene G. Chang, MD6, Gaurav Chawdhary, MD7, Philip Chen, MD8, John P. Dahl, MD, PhD9, Anthony Del Signore, MD10, Carrie Flanagan, MD11, Daniel N. Frank, PhD12, Kai Fruth, MD, PhD13, Anne Getz, MD14, Samuel Greig, MD15, Elisa A. Illing, MD16, David W. Jang, MD17, Yong Gi Jung, MD18, Sammy Khalili, MD, MSc19, Cristobal Langdon, MD20, Kent Lam, MD21, Stella Lee, MD22, Seth Lieberman, MD23, Patricia Loftus, MD24, Luis Macias-Valle, MD25, R. Peter Manes, MD26, Jill Mazza, MD27, Leandra Mfuna, MD28, David Morrissey, MD29, Sue Jean Mun, MD30, Jonathan B. Overdevest, MD, PhD31, Jayant M. Pinto, MD32, Jain Ravi, MD33, Douglas Reh, MD34, Peta L. Sacks, MD35, Michael H. Saste, MD36, John Schneider, MD, MA37, Ahmad R. Sedaghat, MD, PhD38, Zachary M. Soler, MD39, Neville Teo, MD40, Kota Wada, MD41, Kevin Welch, MD42, Troy D. Woodard, MD43, Alan Workman44, Yi Chen Zhao, MD45, David Zopf, MD46 Contributing Author Affiliations 1Universidad de Barcelona; 2University of Pennsylvania; 3Louisiana State University Health Sciences Center; 4Universidade de S?o Paulo; 5ENT Specialists of Illinois; 6University of Arizona; 7University of Oxford; 8University of Texas; 9University of Indiana; 10Mount Sinai Beth Israel; 11Emory University; 12University of Colorado; 13Wiesbaden, Germany; 14University of Colorado; 15University of Alberta; 16University of Alabama at Birmingham; 17Duke University; 18Sungkyunkwan University; 19University of Pennsylvania; 20Universidad de Barcelona; 21Northwestern University; 22University of Pittsburgh; 23New York University; 24Emory University; 25University of British Columbia; 26Yale University School of Medicine; 27Private Practice; 28Department of Otolaryngology, Hôtel-Dieu Hospital, Centre de Recherche du Centre Hospitalier de l'Université de Montréal; 29University of Adelaide; 30Pusan National University; 31University of California, San Francisco; 32University of Chicago; 33University of Auckland; 34Johns Hopkins University; 35University of New South Wales, Australia; 36Stanford University; 37Washington University; 38Harvard Medical School; 39Medical University of South Carolina; 40Singapore General Hospital; 41Taho University; 42Northwestern University; 43Cleveland Clinic Foundation; 44University of Pennsylvania; 45University of Adelaide; 46University of Michigan
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - HPB
VL  - 9
IS  - s1
SN  - 9781119317920
UR  - https://doi.org/10.1080/16515320701258846
DO  - doi:10.1080/16515320701258846
SP  - 36
EP  - 110
PY  - 2007
ER  - 

TY  - JOUR
TI  - P941 - P1197
JO  - Clinical Microbiology and Infection
VL  - 12
IS  - s4
SN  - 9781119317920
UR  - https://doi.org/10.1111/j.1470-9465.2006.12_4_1429.x
DO  - doi:10.1111/j.1470-9465.2006.12_4_1429.x
PY  - 2006
ER  - 

TY  - JOUR
TI  - LECTURES
JO  - Cell Proliferation
VL  - 38
IS  - 4
SN  - 9781119317920
UR  - https://doi.org/10.1111/j.1365-2184.2005.00343_3.x
DO  - doi:10.1111/j.1365-2184.2005.00343_3.x
SP  - 177
EP  - 203
PY  - 2005
ER  - 

TY  - JOUR
TI  - The Winter Scientific Meeting (191st) (incorporating the Trainees' Programme) of the Pathological Society of Great Britain and Ireland. 3 – 5 January 2007. Hosted by the Department of Pathology, Royal Free and University College Medical School, London.
JO  - The Journal of Pathology
JA  - J. Pathol.
VL  - 211
IS  - S1
SN  - 9781119317920
UR  - https://doi.org/10.1002/path.2166
DO  - doi:10.1002/path.2166
SP  - 1A
EP  - 29A
PY  - 2007
ER  - 

AU  - Mathews, Karol
AU  - Grubb, Tamara
C7  - pp. 144-164
TI  - Pharmacologic and Clinical Principles of Adjunct Analgesia
SN  - 9781119036562
UR  - https://doi.org/10.1002/9781119036500.ch12
DO  - doi:10.1002/9781119036500.ch12
SP  - 144-164
KW  - adjunctive analgesics
KW  - corticosteroids
KW  - monoamine oxidase inhibitors
KW  - non-steroidal anti-inflammatory analgesics
KW  - reuptake inhibitors
KW  - ricyclic antidepressants
KW  - selective serotonin
KW  - veterinary medicine
PY  - 2007
AB  - Summary Analgesia, usually provided by opioids and non-steroidal anti-inflammatory analgesics (NSAIAs), can be enhanced by other classes of medication that have a different primary role but with a pharmacological mechanism of action that supports their analgesic actions. Adjunct analgesic methods/medications added to standard opioid and NSAIA analgesia has gained popularity in veterinary medicine; however, there are few veterinary clinical trials assessing efficacy. Adjunctive analgesics are frequently used in combination with other analgesics to confer a synergistic effect in a multi-modal regimen or to facilitate lower drug dosages to reduce adverse effects. Drugs currently used as adjuncts are Lidocaine systemically, Alpha2-adrenergic agonists, Gabapentin, Amitriptyline and Amantadine. This chapter discusses tricyclic antidepressants, selective serotonin reuptake inhibitors, and monoamine oxidase inhibitors. Corticosteroids inhibit cyclooxygenase -2 (COX-2) gene expression, which is upregulated in inflammatory states, reduces aberrant firing originating from nerve injury and reduces inflammation at the site of injury.
ER  - 
